Clinical trials: Coronary Microvascular Dysfunction (CMD)

Coronary Microvascular Dysfunction (CMD), Index of Microvascular Resistance

SHR Predicts CMD in Patients with CCS

• Completed
• Age: 18 years and older
• Observational study
• Medical device

SHR exerts a significant influence in numerous cardiovascular diseases, including MINOCA (myocardial infarction with non - obstructive coronary arteries), HFpEF (heart failure with preserved ejection fraction), and CAD (coronary…

Conditions

Coronary Microvascular Dysfunction (CMD), Index of Microvascular Resistance, Chronic Coronary Syndrome, Prognosis

Trial name

SHR-CMD-CCS (NCT06698432)

Testing

caIMR

Volunteers

379 people

Sponsor

Ya-Wei Xu